All News #Library
Generics
Lotus Grows US Generics Business With Acquisition Of Alvogen
26 Sep 2025 //
PR NEWSWIRE
Alvogen Sells To Lotus, Forming Top Global Specialized Generics
23 Sep 2025 //
PR NEWSWIRE
Alvogen Launches Generic Equivalent to Suboxone® (Buprenorphine/Naloxone)
20 Feb 2019 //
PR NEWSWIRE
Janumet XR (metformin HCl; sitagliptin phosphate) : Merck vs. Alvogen PB
13 Feb 2019 //
PATENT LITIGATION
Belbuca (Buprenorphine) : BioDelivery Sciences v. Alvogen Pb R&D
11 Sep 2018 //
PATENT LITIGATION
Lawmaker urges Pfizer to sue over lethal injection procedure
30 Jul 2018 //
FIERCE PHARMA
Revlimid® (Lenalidomide): Celgene Corporation v. Lotus Pharmaceutical Co., Alvogen Group, Inc.
16 Jul 2018 //
PATENT LITIGATION
Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon
21 Jun 2018 //
PATENT LITIGATION
Generics group Alvogen puts Eastern European ops up for sale: sources
20 Apr 2018 //
REUTERS
Suboxone®(buprenorphine HCL & Naloxone HCL) : Indivior v. Alvogen Pine Brook
03 Apr 2018 //
PATENT LITIGATION
Indivior loses patent battle with generics maker Alvogen
24 Mar 2018 //
ENDPTS
Teva`s Copaxone faces generic competition in Europe after U.S. hit
05 Oct 2017 //
REUTERS
Indivior reaches settlement with Mylan over patent dispute
26 Sep 2017 //
PHARMAFILE
CVC to Explore Options for $4 Billion Drugmaker Alvogen
26 Sep 2017 //
BLOOMBERG
As drug prices drop, generics makers fight back with deals
28 Jul 2017 //
REUTERS
Generic Copy of Roche Flu Pill Tamiflu hits US Market
13 Dec 2016 //
REUTERS
Natco Pharma gets USFDA Nod for Generic Budesonide Capsules
25 Nov 2016 //
ECONOMIC TIMES
Generic alternative to Novartis` transdermal patch for Alzheimer`s hits the market
09 Sep 2015 //
FIERCE DRUG DELIVERY
Generics maker Alvogen eyes faster growth after CVC-led buyout
22 Jun 2015 //
FIERCE PHARMA

Market Place
Sourcing Support